Announce Date | 05/02/2024 |
EPS Normalized Actual | $19.39 (Beat by $8.61) |
EPS GAAP Actual | $19.39 (Beat by $8.61) |
Revenue Actual | $0.426726B |
Revenue Surprise | Beat by $426.726M |
Announce Date | 07/01/2024 (Pre-Market) |
EPS Normalized Estimate | $10.20558 |
EPS GAAP Estimate | $10.20558 |
Revenue Estimate | $0.403810405B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 43.63667 | 7.69 | 42.26019 | 45.28617 | 1 |
Dec 2027 | 42.03 | 7.99 | 40.7042 | 43.61877 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | 28.49 | 28.49 | 0.426726B | 20.03% | 426.73M |
FQ4 2021 (Dec 2021) | 10.76 | 10.76 | 0.432588B | 22.15% | 432.59M |
FQ3 2021 (Sep 2021) | 8.68 | 8.68 | 0.430237B | 21.22% | 430.24M |
FQ2 2021 (Jun 2021) | 17.65 | 17.65 | 0.401749B | 18.28% | 401.75M |
FQ1 2021 (Mar 2021) | 11.41 | 11.41 | 0.341262B | 5.88% | 341.26M |
FQ4 2020 (Dec 2020) | 17.69 | 17.69 | 0.336768B | 5.35% | 336.77M |
FQ3 2020 (Sep 2020) | 11.04 | 11.04 | 0.338962B | 15.92% | 338.96M |
FQ2 2020 (Jun 2020) | 10.72 | 10.72 | 0.328303B | 12.99% | 328.3M |
FQ4 Announce Date
07/01/2024 (Pre-Market)
Consensus EPS Estimates
10.20558
Consensus Revenue Estimates
0.403810405B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 8.74333 | -- | 8.6581 | 8.81874 | 1 |
FQ3 2025 (Jul 2025) | 9.27333 | -- | 9.18293 | 9.35331 | 1 |
FQ2 2025 (Jun 2025) | 9.63 | -- | 9.52626 | 9.7669 | 2 |
FQ1 2025 (Mar 2025) | 9.47 | -- | 9.36798 | 9.60463 | 2 |
FQ4 2024 (Oct 2024) | 9.83221 | -- | 7.98867 | 11.67575 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.39B | -- | 0.39B | 0.4B | 0 |
FQ3 2025 (Jul 2025) | 0.39B | -- | 0.39B | 0.4B | 0 |
FQ2 2025 (Jun 2025) | 0.41B | -- | 0.4B | 0.41B | 1 |
FQ1 2025 (Mar 2025) | 0.41B | -- | 0.4B | 0.41B | 1 |
FQ4 2024 (Oct 2024) | 0.4B | -- | 0.4B | 0.4B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | 28.49 | 28.49 | 100% | |
FQ4 2021 (Dec 2021) | 10.76 | 10.76 | 100% | |
FQ3 2021 (Sep 2021) | 8.68 | 8.68 | 100% | |
FQ2 2021 (Jun 2021) | 17.65 | 17.65 | 100% | |
FQ1 2021 (Mar 2021) | 11.41 | 11.41 | 100% | |
FQ4 2020 (Dec 2020) | 17.69 | 17.69 | 100% | |
FQ3 2020 (Sep 2020) | 11.04 | 11.04 | 100% | |
FQ2 2020 (Jun 2020) | 10.72 | 10.72 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0.43B | $426.73M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.43B | $432.59M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.43B | $430.24M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.4B | $401.75M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0.34B | $341.26M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0.34B | $336.77M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0.34B | $338.96M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.33B | $328.3M | 100% |